<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="381">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 24, 2013</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01431378</url>
  </required_header>
  <id_info>
    <org_study_id>106-2010-GES-0010</org_study_id>
    <nct_id>NCT01431378</nct_id>
  </id_info>
  <brief_title>Pilot Study of Model Based Iterative Reconstruction Using 64-Slice</brief_title>
  <acronym>MBIR</acronym>
  <official_title>Pilot Study of Model Based Iterative Reconstruction Using 64-Slice Multidetector-Row CT Datasets Obtained From the Central Nervous System, Thorax, and Abdomen</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American College of Radiology - Image Metrix</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>GE Healthcare</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being performed to confirm that the new technique, Model-Based Iterative
      Reconstruction (MBIR) with reduced radiation dose can deliver equivalent image quality for
      CT scans compared to current techniques (Filtered Back Projection with Adaptive Statistical
      Iterative Reconstruction (FBP with ASiR) and also to demonstrate that MBIR can improve
      general image quality characteristics at equivalent radiation dose levels.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      See brief summary
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">November 2012</completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Crossover, Time Perspective: Prospective</study_design>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Posterior Fossa Hemorrhage</condition>
  <condition>Lung Cancer</condition>
  <condition>Flank Pain</condition>
  <condition>Urolithiasis</condition>
  <condition>Focal Hepatic Necrosis</condition>
  <arm_group>
    <arm_group_label>CNS</arm_group_label>
    <description>CNS: Known or suspected pathology in the posterior fossa</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thorax</arm_group_label>
    <description>Thorax: Patients referred for staging of a known or suspected lung cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abdomen 1</arm_group_label>
    <description>Abdomen: Patients with acute flank pain and suspected urolithiasis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Abdomen 2</arm_group_label>
    <description>Abdomen: Patients with a known or suspected focal liver lesion</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Population to include women or men 30 years of age or older referred for a CT scan
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or Women 30 years of age or older voluntarily willing to sign an informed
             consent.

          -  Patients indicated for one of the following:

        CNS: Known or suspected pathology in the posterior fossa Thorax: Patients referred for
        staging of a known or suspected lung cancer Abdomen: Patients with acute flank pain and
        suspected urolithiasis or Abdomen: Patients with a known or suspected focal liver lesion

        Exclusion Criteria:

          -  Subjects less than 30 years of age

          -  Pregnant women as confirmed by urine test or current accepted institution standard

          -  If IV contrast is required:

          -  Severe or uncontrolled allergy to iodinated contrast media

          -  Serum creatinine &gt; 1.7 mg/dl or estimated glomerular filtration rate [eGFR] of &lt;60
             mg/min as recorded in medical file or by current accepted institution standard

          -  Unable or unwilling to provide written informed consent by self or legal guardian at
             the time of study enrollment

          -  Unstable physical condition as identified by physician
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114-2696</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaurav Desai</last_name>
      <email>gsdesai@partners.org</email>
    </contact>
    <investigator>
      <last_name>Dushyant Sahani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenda Prince</last_name>
      <email>brenda.prince@duke.edu</email>
    </contact>
    <investigator>
      <last_name>Erik Paulson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Froedtert Memorial Lutheran Hospital</name>
      <address>
        <city>Miwaukee</city>
        <state>Wisconsin</state>
        <zip>53226-3596</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Leininger</last_name>
      <email>mleining@mcw.edu</email>
    </contact>
    <investigator>
      <last_name>William Foley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <lastchanged_date>November 7, 2012</lastchanged_date>
  <firstreceived_date>September 7, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CT scan</keyword>
  <keyword>CNS</keyword>
  <keyword>Thorax</keyword>
  <keyword>Abdomen</keyword>
  <keyword>staging of a known or suspected lung cancer</keyword>
  <keyword>suspected urolithiasis</keyword>
  <keyword>known or suspected focal liver lesion</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Flank Pain</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Urolithiasis</mesh_term>
    <mesh_term>Intracranial Hemorrhages</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
